mantle cell lymphoma

Ready-to-Use Boruzu (Bortezomib) from Amneal and Shilpa Approved by FDA
Xtalks
Tue, 09/10/24 - 04:26 pm
Amneal Pharmaceuticals
Shilpa Medicare
FDA
Boruzu
Multiple Myeloma
mantle cell lymphoma
AstraZeneca reports positive data from Phase III mantle cell lymphoma trial
Clinical Trials Arena
Mon, 06/17/24 - 11:21 am
AstraZeneca
clinical trials
Calquence
MCL
mantle cell lymphoma
Bristol Myers secures another FDA go-ahead for Breyanzi, this time in mantle cell lymphoma
Fierce Pharma
Thu, 05/30/24 - 11:10 pm
Bristol Myers Squibb
Breyanzi
FDA
mantle cell lymphoma
As Imbruvica bows out, AstraZeneca clinches early Calquence win in newly diagnosed MCL
Fierce Pharma
Thu, 05/2/24 - 11:31 am
AbbVie
JNJ
Imbruvica
AstraZeneca
Calquence
mantle cell lymphoma
Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma
Endpoints
Sun, 01/29/23 - 02:14 pm
Eli Lilly
Btk inhibitors
FDA
Merck
mantle cell lymphoma
Jaypirca
AbbVie pens Imbruvica supply pact to support pivotal Oncternal trial
Fierce Biotech
Fri, 07/15/22 - 11:04 am
AbbVie
Oncternal
clinical trials
mantle cell lymphoma
#ASH20: Loxo and Eli Lilly show off PhI/II data for their BTK inhibitor in mantle cell lymphoma
Endpoints
Sat, 12/5/20 - 11:28 pm
ASH2020
Eli Lilly
clinical trials
LOXO-305
Loxo Oncology
mantle cell lymphoma
non-Hodgkin lymphoma
Gilead closes in on second CAR-T approval in US
Pharmaforum
Tue, 02/11/20 - 10:30 am
FDA
Gilead Sciences
Kite Pharma
mantle cell lymphoma
CAR-T
FDA Grants Priority Review For Kite's KTE-X19 BLA
NASDAQ
Mon, 02/10/20 - 10:27 am
Gilead Sciences
Kite Pharma
KTE-X19
priority review
FDA
mantle cell lymphoma
Gilead's Kite files for FDA approval of second CAR-T therapy
Fierce Biotech
Thu, 12/12/19 - 11:27 am
Gilead Sciences
KTE-X19
mantle cell lymphoma
CAR-T
Kite Pharma
China's BeiGene gets FDA approval for drug to treat rare form of lymphoma
Yahoo/Reuters
Thu, 11/14/19 - 07:27 pm
BeiGene
China
FDA
Brukinsa
mantle cell lymphoma
Preclinical data on MD Anderson Cancer Center-developed drug offers hope for Imbruvica-resistant mantle cell lymphoma patients
Endpoints
Sun, 05/12/19 - 01:28 pm
Imbruvica
non-Hodgkin lymphoma
mantle cell lymphoma
JNJ
MD Anderson Cancer Center
AstraZeneca wins US approval for lymphoma drug
Yahoo/AP
Tue, 10/31/17 - 09:24 pm
AstraZeneca
FDA
Calquence
mantle cell lymphoma
AbbVie Is Focused on Label Expansion of Imbruvica in 2017
Market Realist
Tue, 05/2/17 - 11:22 am
AbbVie
Imbruvica
non-Hodgkin's lymphoma
mantle cell lymphoma
graft vs host disease
Standing Up To The Test Of Time: Two Cancer Drugs That Could Survive A Hobbled FDA
Forbes
Thu, 12/8/16 - 09:59 am
FDA
Seattle Genetics
Takeda
Adcetris
Hodgkin's lymphoma
AbbVie
JNJ
Ibruvica
mantle cell lymphoma
3 Breakthrough Drugs Yield 1 Instant Blockbuster
Motley Fool
Sun, 05/25/14 - 10:26 am
Roche
Gazyva
Imbruvica
JNJ
Gilead Sciences
Sovaldi
mantle cell lymphoma
chronic lymphocytic leukemia
leukemia
Biogen
hepatitis
hepatitus C
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
Thu, 05/15/14 - 08:29 am
ASCO
Gilead Sciences
AbbVie
Pharmacyclics
Imbruvica
CLL
Idelalisib
mantle cell lymphoma
ABT-199
Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
Seeking Alpha
Fri, 01/3/14 - 11:56 am
Pharmacyclics
Imbruvica
JNJ
Roche
Celgene
Gilead Sciences
mantle cell lymphoma
Celgene and Pharmacyclics Bring Big Change to Mantle Cell Lymphoma in 2013
Motley Fool
Sat, 12/14/13 - 12:03 pm
Celgene Corporation
Pharmacyclics
mantle cell lymphoma
JNJ
Imbruvica
Revlimid
Johnson & Johnson’s Imbruvica Will Be a Costly Treatment
Wall St Cheat Sheet
Mon, 11/18/13 - 04:36 pm
JNJ
Imbruvica
mantle cell lymphoma
Pharmacyclics

Pages